Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazine$390bn wiped off global drug sales forecasts
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Big News
Editor's View
Great Ideas Update
Investment Trusts
Larger Companies
Main Feature
Money Matters
Smaller Companies
Story In Numbers
- Petropavlovsk co-founder kicked off the board after 23 years’ service
- Which FTSE 350 Shares have Lost Shareholders Money
- Which FTSE 350 Shares Rewarded Shareholders
- $390bn wiped off global drug sales forecasts
- 98.6% vote in favour of Standard Life/Aberdeen merger
- London’s shrinking bank industry
- 150M Hurricane blows Crystal Amber down
